Targeting a mitochondrial potassium channel to fight cancer

Cell Calcium

Volumn 58, Issue 1, 2015, Pages 131-138

  Leanza, Luigi ^a   Venturini, Elisa ^b   Kadow, Stephanie ^b   Carpinteiro, Alexander ^b   Gulbins, Erich ^b   Becker, Katrin Anne ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Bax; Cell death; Mitochondria; Potassium channel; Toxins

Indexed keywords

CHARYBDOTOXIN; CLOFAZIMINE; MARGATOXIN; MITOCHONDRIAL POTASSIUM CHANNEL KV1.3; PAP 1; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL KV1.3; PSORA 4; REACTIVE OXYGEN METABOLITE; STICHODACTYLA HELIANTUS TOXIN; TOXIN; UNCLASSIFIED DRUG; POTASSIUM; POTASSIUM CHANNEL; PROTEIN BCL 2;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CHEMOTHERAPY; CELL DEATH; CHRONIC LYMPHATIC LEUKEMIA; DRUG TARGETING; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; ANIMAL; CHEMISTRY; DRUG EFFECTS; GENETICS; METABOLISM; NEOPLASMS; PATHOLOGY;

ANIMALS; APOPTOSIS; HUMANS; MITOCHONDRIA; NEOPLASMS; POTASSIUM; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES;

EID: 84930532213     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2014.09.006     Document Type: Review

References (96)

1. Wyllie A.H., Golstein P. More than one way to go. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:11-13.
2. Green D.R., Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004, 305:626-629.
3. Westphal D., Kluck R.M., Dewson G. Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis. Cell Death Differ. 2014, 21:196-205.
4. Antignani A., Youle R.J. How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane?. Curr. Opin. Cell Biol. 2006, 18:685-689.
5. Antonsson B., Montessuit S., Sanchez B., Martinou J.C. Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J. Biol. Chem. 2001, 276:11615-11623.
6. Schlesinger P.H., Saito M. The Bax pore in liposomes, biophysics. Cell Death Differ. 2006, 13:1403-1408.
7. Daniel P.T., Schulze-Osthoff K., Belka C., Guner D. Guardians of cell death: the Bcl-2 family proteins. Essays Biochem. 2003, 39:73-88.
8. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993, 75:241-251.
9. Antonsson B., Montessuit S., Lauper S., Eskes R., Martinou J.C. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem. J. 2000, 345(Pt 2):271-278.
10. Annis M.G., Soucie E.L., Dlugosz P.J., Cruz-Aguado J.A., Penn L.Z., Leber B., Andrews D.W. Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis. EMBO J. 2005, 24:2096-2103.
11. Skulachev V.P. Cytochrome c in the apoptotic and antioxidant cascades. FEBS Lett. 1998, 423:275-280.
12. Cheng E.H., Wei M.C., Weiler S., Flavell R.A., Mak T.W., Lindsten T., Korsmeyer S.J. BCL-2 BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell 2001, 8:705-711.
13. Ott M., Robertson J.D., Gogvadze V., Zhivotovsky B., Orrenius S. Cytochrome c release from mitochondria proceeds by a two-step process. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:1259-1263.
14. Iverson S.L., Orrenius S. The cardiolipin-cytochrome c interaction and the mitochondrial regulation of apoptosis. Arch. Biochem. Biophys. 2004, 423:37-46.
15. Narita M., Shimizu S., Ito T., Chittenden T., Lutz R.J., Matsuda H., Tsujimoto Y. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:14681-14686.
16. Skulachev V.P. Why are mitochondria involved in apoptosis? Permeability transition pores and apoptosis as selective mechanisms to eliminate superoxide-producing mitochondria and cell. FEBS Lett. 1996, 397:7-10.
17. Gutman G.A., Chandy K.G., Grissmer S., Lazdunski M., McKinnon D., Pardo L.A., Robertson G.A., Rudy B., Sanguinetti M.C., Stuhmer W., Wang X. International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol. Rev. 2005, 57:473-508.
18. Cahalan M.D., Chandy K.G. The functional network of ion channels in T lymphocytes. Immunol. Rev. 2009, 231:59-87.
19. Tytgat J. Mutations in the P-region of a mammalian potassium channel (RCK1): a comparison with the Shaker potassium channel. Biochem. Biophys. Res. Commun. 1994, 203:513-518.
20. Aiyar J., Rizzi J.P., Gutman G.A., Chandy K.G. The signature sequence of voltage-gated potassium channels projects into the external vestibule. J. Biol. Chem. 1996, 271:31013-31016.
21. Bright J.N., Shrivastava I.H., Cordes F.S., Sansom M.S. Conformational dynamics of helix S6 from Shaker potassium channel: simulation studies. Biopolymers 2002, 64:303-313.
22. Treptow W., Maigret B., Chipot C., Tarek M. Coupled motions between pore and voltage-sensor domains: a model for Shaker B, a voltage-gated potassium channel. Biophys. J. 2004, 87:2365-2379.
23. + channel in a lipid membrane-like environment. Nature 2007, 450:376-382.
24. Armstrong C.M. Voltage-gated K channels. Sci. STKE 2003, 2003:re10.
25. Gutman G.A., Chandy K.G., Adelman J.P., Aiyar J., Bayliss D.A., Clapham D.E., Covarriubias M., Desir G.V., Furuichi K., Ganetzky B., Garcia M.L., Grissmer S., Jan L.Y., Karschin A., Kim D., Kuperschmidt S., Kurachi Y., Lazdunski M., Lesage F., Lester H.A., McKinnon D., Nichols C.G., O'Kelly I., Robbins J., Robertson G.A., Rudy B., Sanguinetti M., Seino S., Stuehmer W., Tamkun M.M., Vandenberg C.A., Wei A., Wulff H., Wymore R.S. International Union of Pharmacology. XLI. Compendium of voltage-gated ion channels: potassium channels. Pharmacol. Rev. 2003, 55:583-586.
26. MacKinnon R. Potassium channels. FEBS Lett. 2003, 555:62-65.
27. O'Grady S.M., Lee S.Y. Molecular diversity and function of voltage-gated (Kv) potassium channels in epithelial cells. Int. J. Biochem. Cell Biol. 2005, 37:1578-1594.
28. Leanza L., Zoratti M., Gulbins E., Szabo I. Mitochondrial ion channels as oncological targets. Oncogene 2014, in press. 10.1038/onc.2013.578.
29. Szabò I., Adams C., Gulbins E. Ion channels and membrane rafts in apoptosis. Pflugers Arch. 2004, 448:304-312.
30. Szabò I., Zoratti M., Gulbins E. Contribution of voltage-gated potassium channels to the regulation of apoptosis. FEBS Lett. 2010, 584:2049-2056.
31. + channel blockers on spontaneous glycine release at rat spinal neurons. Brain Res. 2007, 1157:11-22.
32. Xu J., Koni P.A., Wang P., Li G., Kaczmarek L., Wu Y., Li Y., Flavell R.A., Desir G.V. The voltage-gated potassium channel Kv1.3 regulates energy homeostasis and body weight. Hum. Mol. Genet. 2003, 12:551-559.
33. 2+ signalling and platelet count. J. Physiol. 2010, 588:1399-1406.
34. Koni P.A., Khanna R., Chang M.C., Tang M.D., Kaczmarek L.K., Schlichter L.C., Flavell R.A. Compensatory anion currents in Kv1.3 channel-deficient thymocytes. J. Biol. Chem. 2003, 278:39443-39451.
35. Beeton C., Pennington M.W., Wulff H., Singh S., Nugent D., Crossley G., Khaytin I., Calabresi P.A., Chen C.Y., Gutman G.A., Chandy K.G. Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases. Mol. Pharmacol. 2005, 67:1369-1381.
36. 4+ T lymphocytes. J. Immunol. 2007, 179:4563-4570.
37. Kalman K., Pennington M.W., Lanigan M.D., Nguyen A., Rauer H., Mahnir V., Paschetto K., Kem W.R., Grissmer S., Gutman G.A., Christian E.P., Cahalan M.D., Norton R.S., Chandy K.G. ShK-Dap22 a potent Kv1.3-specific immunosuppressive polypeptide. J. Biol. Chem. 1998, 273:32697-32707.
38. Lanigan M.D., Kalman K., Lefievre Y., Pennington M.W., Chandy K.G., Norton R.S. Mutating a critical lysine in ShK toxin alters its binding configuration in the pore-vestibule region of the voltage-gated potassium channel, Kv1.3. Biochemistry 2002, 41:11963-11971.
39. + channels and inhibits T lymphocyte proliferation. J. Biol. Chem. 2008, 283:988-997.
40. Rauer H., Pennington M., Cahalan M., Chandy K.G. Structural conservation of the pores of calcium-activated and voltage-gated potassium channels determined by a sea anemone toxin. J. Biol. Chem. 1999, 274:21885-21892.
41. Vennekamp J., Wulff H., Beeton C., Calabresi P.A., Grissmer S., Hansel W., Chandy K.G. Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators. Mol. Pharmacol. 2004, 65:1364-1374.
42. Bohuslavizki K.H., Hansel W., Kneip A., Koppenhofer E., Niemoller E., Sanmann K. Mode of action of psoralens, benzofurans, acridinons, and coumarins on the ionic currents in intact myelinated nerve fibres and its significance in demyelinating diseases. Gen. Physiol. Biophys. 1994, 13:309-328.
43. Schmitz A., Sankaranarayanan A., Azam P., Schmidt-Lassen K., Homerick D., Hansel W., Wulff H. Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases. Mol. Pharmacol. 2005, 68:1254-1270.
44. Ren Y.R., Pan F., Parvez S., Fleig A., Chong C.R., Xu J., Dang Y., Zhang J., Jiang H., Penner R., Liu J.O. Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes. PLoS ONE 2008, 3:e4009.
45. Karat A.B., Jeevaratnam A., Karat S., Rao P.S. Double-blind controlled clinical trial of clofazimine in reactive phases of lepromatous leprosy. Br. Med. J. 1970, 1:198-200.
46. Dooley K.E., Obuku E.A., Durakovic N., Belitsky V., Mitnick C., Nuermberger E.L. World Health Organization group 5 drugs for the treatment of drug-resistant tuberculosis: unclear efficacy or untapped potential?. J. Infect. Dis. 2013, 207:1352-1358.
47. Morrison N.E., Marley G.M. Clofazimine binding studies with deoxyribonucleic acid. Int. J. Lepr. Other Mycobact. Dis. 1976, 44:475-481.
48. Szabò I., Bock J., Jekle A., Soddemann M., Adams C., Lang F., Zoratti M., Gulbins E. A novel potassium channel in lymphocyte mitochondria. J. Biol. Chem. 2005, 280:12790-12798.
49. Szabò I., Bock J., Grassme H., Soddemann M., Wilker B., Lang F., Zoratti M., Gulbins E. Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14861-14866.
50. + channel in macrophages. J. Biol. Chem. 2006, 281:37675-37685.
51. Leanza L., Biasutto L., Manago A., Gulbins E., Zoratti M., Szabò I. Intracellular ion channels and cancer. Front Physiol. 2013, 4:227.
52. Bernardi P. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol. Rev. 1999, 79:1127-1155.
53. + uniport in intact mitochondria by adenine nucleotides and nucleotide analogs. J. Biol. Chem. 1993, 268:997-1004.
54. Mitchell P., Moyle J. Stoichiometry of proton translocation through the respiratory chain and adenosine triphosphatase systems of rat liver mitochondria. Nature 1965, 208:147-151.
55. Mitchell P., Moyle J. Chemiosmotic hypothesis of oxidative phosphorylation. Nature 1967, 213:137-139.
56. Szabò I., Leanza L., Gulbins E., Zoratti M. Physiology of potassium channels in the inner membrane of mitochondria. Pflugers Arch. 2012, 463:231-246.
57. Szabò I., Zoratti M. Mitochondrial channels: ion fluxes and more. Parasitol. Res. 2014, 94:519-608.
58. Azzone G.F., Bragadin M., Pozzan T., Antone P.D. Proton electrochemical potential in steady state rat liver mitochondria. Biochim. Biophys. Acta 1977, 459:96-109.
59. Massari S., Balboni E., Azzone G.F. Distribution of permeant cations in rat liver mitochondria under steady-state conditions. Biochim. Biophys. Acta 1972, 283:16-22.
60. + influx increases respiration and enhances ROS production while maintaining membrane potential. Am. J. Physiol. Cell Physiol. 2007, 292:C148-C156.
61. Garlid K.D. Sodium/proton antiporters in the mitochondrial inner membrane. Adv. Exp. Med. Biol. 1988, 232:37-46.
62. + uniports and exchangers. J. Bioenerg. Biomembr. 1994, 26:519-526.
63. Halestrap A.P. The regulation of the matrix volume of mammalian mitochondria in vivo and in vitro and its role in the control of mitochondrial metabolism. Biochim. Biophys. Acta 1989, 973:355-382.
64. Quast S.A., Berger A., Buttstadt N., Friebel K., Schonherr R., Eberle J. General sensitization of melanoma cells for TRAIL-induced apoptosis by the potassium channel inhibitor TRAM-34 depends on release of SMAC. PLoS ONE 2012, 7:e39290.
65. + channel in the mitochondrial inner membrane. Nature 1991, 352:244-247.
66. Starkov A.A. The role of mitochondria in reactive oxygen species metabolism and signaling. Ann. N. Y. Acad. Sci. 2008, 1147:37-52.
67. Murphy M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417:1-13.
68. Pinton P., Rizzuto R. p66Shc, oxidative stress and aging: importing a lifespan determinant into mitochondria. Cell Cycle 2008, 7:304-308.
69. Pani G., Koch O.R., Galeotti T. The p53-p66shc-manganese superoxide dismutase (MnSOD) network: a mitochondrial intrigue to generate reactive oxygen species. Int. J. Biochem. Cell Biol. 2009, 41:1002-1005.
70. Di Lisa F., Kaludercic N., Carpi A., Menabo R., Giorgio M. Mitochondrial pathways for ROS formation and myocardial injury: the relevance of p66(Shc) and monoamine oxidase. Basic Res. Cardiol. 2009, 104:131-139.
71. Selivanov V.A., Votyakova T.V., Pivtoraiko V.N., Zeak J., Sukhomlin T., Trucco M., Roca J., Cascante M. Reactive oxygen species production by forward and reverse electron fluxes in the mitochondrial respiratory chain. PLoS Comput. Biol. 2011, 7:e1001115.
72. Orr A.L., Quinlan C.L., Perevoshchikova I.V., Brand M.D. A refined analysis of superoxide production by mitochondrial sn-glycerol 3-phosphate dehydrogenase. J. Biol. Chem. 2012, 287:42921-42935.
73. Kadenbach B. Intrinsic and extrinsic uncoupling of oxidative phosphorylation. Biochim. Biophys. Acta 2003, 1604:77-94.
74. Korshunov S.S., Skulachev V.P., Starkov A.A. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 1997, 416:15-18.
75. Skulachev V.P. Uncoupling: new approaches to an old problem of bioenergetics. Biochim. Biophys. Acta 1998, 1363:100-124.
76. Malinska D., Mirandola S.R., Kunz W.S. Mitochondrial potassium channels and reactive oxygen species. FEBS Lett. 2010, 584:2043-2048.
77. + channels in the cardiac inner mitochondrial membrane. Science 2002, 298:1029-1033.
78. Garlid K.D., Dos Santos P., Xie Z.J., Costa A.D., Paucek P. Mitochondrial potassium transport: the role of the mitochondrial ATP-sensitive K(+) channel in cardiac function and cardioprotection. Biochim. Biophys. Acta 2003, 1606:1-21.
79. Cheng Y., Gulbins E., Siemen D. Activation of the permeability transition pore by Bax via inhibition of the mitochondrial BK channel. Cell. Physiol. Biochem. 2011, 27:191-200.
80. 2+-activated K channel of the BK-type in the inner mitochondrial membrane of a human glioma cell line. Biochem. Biophys. Res. Commun. 1999, 257:549-554.
81. Leanza L., Henry B., Sassi N., Zoratti M., Chandy K.G., Gulbins E., Szabò I. Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells. EMBO Mol. Med. 2012, 4:577-593.
82. Szabò I., Soddemann M., Leanza L., Zoratti M., Gulbins E. Single-point mutations of a lysine residue change function of Bax and Bcl-xL expressed in Bax- and Bak-less mouse embryonic fibroblasts: novel insights into the molecular mechanisms of Bax-induced apoptosis. Cell Death Differ. 2011, 18:427-438.
83. Leanza L., Trentin L., Becker K.A., Frezzato F., Zoratti M., Semenzato G., Gulbins E., Szabò I. Clofazimine, Psora-4 PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia. Leukemia 2013, 27:1782-1785.
84. Leanza L., Zoratti M., Gulbins E., Szabò I. Induction of apoptosis in macrophages via Kv1.3 and Kv1.5 potassium channels. Curr. Med. Chem. 2012, 19:5394-5404.
85. Bednarczyk P., Kowalczyk J.E., Beresewicz M., Dolowy K., Szewczyk A., Zablocka B. Identification of a voltage-gated potassium channel in gerbil hippocampal mitochondria. Biochem. Biophys. Res. Commun. 2010, 397:614-620.
86. Cheng Y., Debska-Vielhaber G., Siemen D. Interaction of mitochondrial potassium channels with the permeability transition pore. FEBS Lett. 2010, 584:2005-2012.
87. Arcangeli A., Crociani O., Lastraioli E., Masi A., Pillozzi S., Becchetti A. Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. Curr. Med. Chem. 2009, 16:66-93.
88. Alizadeh A.A., Eisen M.B., Davis R.E., Ma C., Lossos I.S., Rosenwald A., Boldrick J.C., Sabet H., Tran T., Yu X., Powell J.I., Yang L., Marti G.E., Moore T., Hudson J., Lu L., Lewis D.B., Tibshirani R., Sherlock G., Chan W.C., Greiner T.C., Weisenburger D.D., Armitage J.O., Warnke R., Levy R., Wilson W., Grever M.R., Byrd J.C., Botstein D., Brown P.O., Staudt L.M. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511.
89. Artym V.V., Petty H.R. Molecular proximity of Kv1.3 voltage-gated potassium channels and beta(1)-integrins on the plasma membrane of melanoma cells: effects of cell adherence and channel blockers. J. Gen. Physiol. 2002, 120:29-37.
90. Preussat K., Beetz C., Schrey M., Kraft R., Wolfl S., Kalff R., Patt S. Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas. Neurosci. Lett. 2003, 346:33-36.
91. Abdul M., Santo A., Hoosein N. Activity of potassium channel-blockers in breast cancer. Anticancer Res. 2003, 23:3347-3351.
92. Jang S.H., Kang K.S., Ryu P.D., Lee S.Y. Kv1.3 voltage-gated K(+) channel subunit as a potential diagnostic marker and therapeutic target for breast cancer. BMB Rep. 2009, 42:535-539.
93. Abdul M., Hoosein N. Reduced Kv1.3 potassium channel expression in human prostate cancer. J. Membr. Biol. 2006, 214:99-102.
94. Lan M., Shi Y., Han Z., Hao Z., Pan Y., Liu N., Guo C., Hong L., Wang J., Qiao T., Fan D. Expression of delayed rectifier potassium channels and their possible roles in proliferation of human gastric cancer cells. Cancer Biol. Ther. 2005, 4:1342-1347.
95. Abdul M., Hoosein N. Voltage-gated potassium ion channels in colon cancer. Oncol. Rep. 2002, 9:961-964.
96. Gulbins E., Sassi N., Grassme H., Zoratti M., Szabò I. Role of Kv1.3 mitochondrial potassium channel in apoptotic signalling in lymphocytes. Biochim. Biophys. Acta 2010, 1797:1251-1259.